Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 0.64 |
| ▸ | CASP14 | P31944 | 1/20 | 0.64 |
| ▸ | CASP3 | P42574 | 1/20 | 0.64 |
| ▸ | CASP2 | P42575 | 1/20 | 0.64 |
| ▸ | CASP4 | P49662 | 1/20 | 0.64 |
| ▸ | CASP5 | P51878 | 1/20 | 0.64 |
| ▸ | CASP7 | P55210 | 1/20 | 0.64 |
| ▸ | CASP9 | P55211 | 1/20 | 0.64 |
| ▸ | CASP6 | P55212 | 1/20 | 0.64 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.64 |
| ▸ | CASP12 | Q6UXS9 | 1/20 | 0.64 |
| ▸ | CASP10 | Q92851 | 1/20 | 0.64 |
| ▸ | EGFR | P00533 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | PDE5A | O76074 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13056961 | 0.81 | CASP1 (0.69) | CASP1CASP14CASP3CASP2CASP4 | |
| SCHEMBL3758852 | 0.78 | CASP1 (1.00) | CASP1CASP14CASP3CASP2CASP4 | |
| SCHEMBL13056962 | 0.78 | ABCG2 (0.64) | CASP1CASP14CASP3CASP2CASP4 | |
| SCHEMBL13081649 | 0.76 | ALDH1A1 (0.41) | CASP1CASP14CASP3CASP2CASP4 | |
| SCHEMBL13082148 | 0.76 | NPC1 (0.43) | CASP1CASP14CASP3CASP2CASP4 | |
| SCHEMBL13056960 | 0.76 | CASP1 (0.59) | CASP1CASP14CASP3CASP2CASP4 | |
| SCHEMBL4074929 | 0.72 | CASP1 (0.73) | CASP1CASP14CASP3CASP2CASP4 | |
| SCHEMBL12060779 | 0.70 | ALDH1A1 (0.61) | CASP3ALDH1A1TP53TSHRMAPK1 | |
| SCHEMBL12060778 | 0.67 | ALDH1A1 (0.47) | ALDH1A1TP53TSHRMAPK1HIF1A | |
| SCHEMBL12060766 | 0.66 | ALDH1A1 (0.55) | CASP3ALDH1A1TP53TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7842805-B2 | Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof | MYREXIS, INC. (US) | 2010-11-30 | — | — | US | disclosed |
| US-20080020985-A1 | PHARMACEUTICAL COMPOUNDS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF | MYRIAD GENETICS, INC. (US) | 2008-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080020985-A1 | PHARMACEUTICAL COMPOUNDS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF | CASP3, CASP2, CASP5 | CASP1 10/4885CASP14 4/4885CASP3 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.